Business Wire

REPLY

6.3.2024 09:31:32 CET | Business Wire | Press release

Share
REPLY: Intel and Concept Reply Join Forces to Pioneer AI-Powered Advancements in Self-Driving Vehicle Safety

Concept Reply, a leader in IoT solutions in the Reply network announces the launch of a groundbreaking AI-driven innovation poised to transform the safety and efficiency of autonomous vehicles, in collaboration with Intel. Drawing on their collective expertise, this advanced AI solution enables precise traffic light detection, bolstering road safety in urban environments.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240306685754/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

By harnessing the power of machine learning, Intel Habana Gaudi processors, and AWS, Concept Reply created an advanced AI-based solution that allows autonomous vehicles to accurately detect traffic lights, improving road safety in urban areas. (Photo: Business Wire)

At the core of this solution lies CARLA, a sophisticated platform designed to simulate complex car sensor functionalities, including GPS, LIDAR, and accelerometers. CARLA facilitates precise simulations of various driving scenarios, such as nighttime driving and diverse weather conditions. This innovative approach allowed to fine-tune the algorithms and elevate the precision of the solution.

Ensuring the reliability and precision of CARLA's robust capabilities demands extensive machine learning training. Traditionally, GPUs have been the preferred choice for this task. However, in light of the current shortage of GPUs, Concept Reply pursued innovative alternatives. In this pursuit, Intel emerged as the perfect choice.

Intel stands as a prominent industry leader, shaping groundbreaking hardware, software, and service technologies. They specialize in embedding intelligence and AI across the entire spectrum of computing devices, from the cloud to the edge, thus unlocking the full potential of data.
This is what drew Concept Reply to Intel, in addition to the expert collaboration and perseverance to accomplish this goal. The result delivered a powerful solution that seamlessly integrates with cloud instances, optimized by Intel. This cutting-edge platform possesses the flexibility to dynamically scale, effortlessly accommodating varying numbers of vehicles during peak hours while efficiently conserving resources during quieter times and running with sustainable computing in mind.

By pioneering this AI-driven solution in collaboration with Intel, Concept Reply aims to set new benchmarks in autonomous vehicle safety. Beyond its application in self-driving cars, this solution also extends its benefits to individuals with color blindness or color vision deficiencies (CVD), contributing to safer roads for everyone.

To learn more about this groundbreaking solution, click here.

Reply
Reply [EXM, STAR: REY] specialises in the design and implementation of solutions based on new communication channels and digital media. As a network of highly specialised companies, Reply defines and develops business models enabled by the new models of AI, big data, cloud computing, digital media and the internet of things. Reply delivers consulting, system integration and digital services to organisations across the telecom and media; industry and services; banking and insurance; and public sectors. www.reply.com

Concept Reply
Concept Reply specializes in the research, development, and validation of innovative solutions in the IoT (Internet of Things) field, with a focus on automotive, manufacturing, and smart infrastructure sectors. Today, we are recognized as a center of expertise and excellence in Testing and Quality Assurance and include a Business Unit that specializes in this service. Thanks to our laboratories and to an international team of professionals specializing in the QA and Validation fields, we are able to offer companies end-to-end support for the validation of products and services, while also optimizing costs and time-to-market. www.concept.reply.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240306685754/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release

Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release

Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d

Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release

A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release

New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release

Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye